Elite in Transient Ischemic Attack (TIA)

Shelagh B. Coutts

Calgary, AB, CA 
Elite in Transient Ischemic Attack (TIA)
Calgary, AB, CA 
OverviewLocationsClinical Research

Overview

Shelagh Coutts practices in Calgary, Canada. Ms. Coutts is rated as an Elite expert by MediFind in the treatment of Transient Ischemic Attack (TIA). Her top areas of expertise are Transient Ischemic Attack (TIA), Stroke, Carotid Artery Disease, Patent Foramen Ovale, and Thrombectomy.

Her clinical research consists of co-authoring 191 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 89 articles and participated in 3 clinical trials in the study of Transient Ischemic Attack (TIA).

Gender
Female

Locations

Calgary, AB, Canada
Other Locations
Canada
Hamilton, ON, Canada
Sherbrooke, QC, Canada
Edmonton, AB, Canada
Montreal, QC, Canada
Hotchkiss, AB, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke: QuICR & OPTIMISE Registry Based Pragmatic Randomized Controlled Trial
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke: QuICR & OPTIMISE Registry Based Pragmatic Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: May 12, 2023
Intervention Type: Drug
Study Drugs: Tenecteplase, Alteplase
Study Phase: Phase 3
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Early Anticoagulation With Rivaroxaban Versus Standard of Care in Determining Safety at 365 Days in Symptomatic Cerebral Venous Thrombosis
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Early Anticoagulation With Rivaroxaban Versus Standard of Care in Determining Safety at 365 Days in Symptomatic Cerebral Venous Thrombosis
Enrollment Status: Completed
Publish Date: December 14, 2022
Intervention Type: Drug
Study Drug: Rivaroxaban
Study Phase: Phase 2
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Enrollment Status: Completed
Publish Date: March 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Drug
Study Phase: Phase 2
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 2-Validation of Clinical Features and Protein Biomarkers
Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 2-Validation of Clinical Features and Protein Biomarkers
Enrollment Status: Completed
Publish Date: August 18, 2017
Intervention Type: Other
View 6 Less Clinical Trials

191 Total Publications

Disparities in Access to Vascular Stroke Imaging and Carotid Revascularization: A Population Study.
Disparities in Access to Vascular Stroke Imaging and Carotid Revascularization: A Population Study.
Journal: Journal of the American Heart Association
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Coutts's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile